It will be important to test GEF-H1 inhibitors in the future and directly compare their effectiveness for the treatment of uveitis with current standard treatments such as dexamethasone, a treatment with considerable side effects [64,65]. This evidence concerns the gene ARHGEF2 and uveitis.